K12 HD00849/HD/NICHD NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1995	1
1996	1
1997	1
2006	1
2007	1
2008	1
2009	1
2010	1
2011	1
2012	3
2013	3
2014	1
2015	1
2024	0

1

GPR54 and KiSS-1: role in the regulation of puberty and reproduction.

Kuohung W, Kaiser UB. Kuohung W, et al. Rev Endocr Metab Disord. 2006 Dec;7(4):257-63. doi: 10.1007/s11154-006-9020-2. Rev Endocr Metab Disord. 2006. PMID: 17206526 Review.

2

The role of the fallopian tube in the origin of ovarian cancer.

Erickson BK, Conner MG, Landen CN Jr. Erickson BK, et al. Am J Obstet Gynecol. 2013 Nov;209(5):409-14. doi: 10.1016/j.ajog.2013.04.019. Epub 2013 Apr 10. Am J Obstet Gynecol. 2013. PMID: 23583217 Free PMC article. Review.

3

The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer.

Dobbin ZC, Landen CN. Dobbin ZC, et al. Int J Mol Sci. 2013 Apr 15;14(4):8213-27. doi: 10.3390/ijms14048213. Int J Mol Sci. 2013. PMID: 23591839 Free PMC article. Review.

4

Relevance of molecular medicine to clinical obstetrics and gynecology.

Cohen DP, Layman LC. Cohen DP, et al. Obstet Gynecol Surv. 1997 Jan;52(1):73-80. doi: 10.1097/00006254-199701000-00025. Obstet Gynecol Surv. 1997. PMID: 8994240 Review.

5

Isolation and characterization of potential cancer stem cells from solid human tumors--potential applications.

Dobbin ZC, Landen CN. Dobbin ZC, et al. Curr Protoc Pharmacol. 2013 Dec 2;63:14.28.1-14.28.19. doi: 10.1002/0471141755.ph1428s63. Curr Protoc Pharmacol. 2013. PMID: 24510756 Free PMC article.

6

Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Landen CN, Kim TJ, Lin YG, Merritt WM, Kamat AA, Han LY, Spannuth WA, Nick AM, Jennnings NB, Kinch MS, Tice D, Sood AK. Landen CN, et al. Neoplasia. 2008 Nov;10(11):1259-67. doi: 10.1593/neo.08740. Neoplasia. 2008. PMID: 18953435 Free PMC article.

7

Smoothened antagonists reverse taxane resistance in ovarian cancer.

Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN. Steg AD, et al. Mol Cancer Ther. 2012 Jul;11(7):1587-97. doi: 10.1158/1535-7163.MCT-11-1058. Epub 2012 May 2. Mol Cancer Ther. 2012. PMID: 22553355 Free PMC article.

8

Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.

Kim TJ, Landen CN, Lin YG, Mangala LS, Lu C, Nick AM, Stone RL, Merritt WM, Armaiz-Pena G, Jennings NB, Coleman RL, Tice DA, Sood AK. Kim TJ, et al. Cancer Biol Ther. 2009 Dec;8(23):2263-72. doi: 10.4161/cbt.8.23.10134. Epub 2009 Dec 19. Cancer Biol Ther. 2009. PMID: 19829059 Free PMC article.

9

Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer.

Brouwer-Visser J, Lee J, McCullagh K, Cossio MJ, Wang Y, Huang GS. Brouwer-Visser J, et al. PLoS One. 2014 Jun 16;9(6):e100165. doi: 10.1371/journal.pone.0100165. eCollection 2014. PLoS One. 2014. PMID: 24932685 Free PMC article.

10

Demonstration of multipotent stem cells in the adult human endometrium by in vitro chondrogenesis.

Wolff EF, Wolff AB, Hongling Du, Taylor HS. Wolff EF, et al. Reprod Sci. 2007 Sep;14(6):524-33. doi: 10.1177/1933719107306896. Reprod Sci. 2007. PMID: 17959881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year